M. Clemente

Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.

G. Albero, X. Castellsagué, J. Dorca, 2012, Archives of internal medicine.

Healthcare-Associated Mycobacterium bovis–Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation

A. Orcau, J. Caylà, M. Vaqué, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol

C. Tebé, S. Videla, J. Niubó, 2020, BMJ Open.

Angiokeratoma corporis diffusum and arteriovenous fistulas with dominant transmission in the absence of metabolic disorders.

P. Calzavara-Pinton, F. Facchetti, N. Zoppi, 1995, Archives of dermatology.

Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study

J. Costa, M. Vaqué, J. Gali, 2021, Clinical Microbiology and Infection.

Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes

J. Niubó, J. Carratalá, C. Ardanuy, 2020, Open forum infectious diseases.

Non-intravenous carbapenem-sparing antibiotics for the definitive treatment of bacteremia due to Enterobacteriaceae-producing ESBL or AmpC β-lactamase. A propensity score study.

J. Rodríguez-Baño, M. Sierra, C. Pigrau, 2019, International journal of antimicrobial agents.

Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

C. Tebé, S. Videla, J. Niubó, 2020, Trials.